Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study

Mise à jour : Il y a 4 ans
Référence : NCT00687791

Femme et Homme

  • | Pays :
  • Singapore
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of this study is to determine the safety and effectiveness of the OculusGen™ (ologen) Biodegradable Collagen Matrix Implant in hacotrabeculectomy surgery. The primary endpoint is to prove the effectiveness via the reduction of IOP, and the secondary endpoint is to prove the safety via the incidence of complications and adverse events.


Critère d'inclusion

  • Cataract ,Glaucoma

Liens